Jinshi Biological: The application for the new drug Roche's Keytruda injection has been accepted for market approval.

Jinshi Biotech announced that the company recently received a decision from the National Medical Products Administration regarding the acceptance of the application for the market authorization of Roche's Bevacizumab Injection. The National Medical Products Administration believes that, according to the Drug Administration Law of the People's Republic of China and relevant regulations, the drug meets the conditions for acceptance of the application for market authorization.